Siena Salvatore

Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer / A. Lorenzato, A. Magrì, V. Matafora, V. Audrito, P. Arcella, L. Lazzari, M. Montone, S. Lamba, S. Deaglio, S. Siena, A. Bertotti, L. Trusolino, A. Bachi, F. Di Nicolantonio, A. Bardelli, S. Arena. - In: CANCERS. - ISSN 2072-6694. - 12:3(2020 Mar 14), pp. 685.1-685.22.

Central Nervous System as Possible Site of Relapse in ERBB2-PositiveMetastatic Colorectal Cancer:Long-term Results of TreatmentWith Trastuzumab and Lapatinib / A. Sartore Bianchi, S. Lonardi, M. Aglietta, C. Martino, F. Ciardiello, S. Marsoni, S. Siena. - In: JAMA ONCOLOGY. - ISSN 2374-2437. - (2020 Mar). [Epub ahead of print]

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials / R.C. Doebele, A. Drilon, L. Paz-Ares, S. Siena, A.T. Shaw, A.F. Farago, C.M. Blakely, T. Seto, B.C. Cho, D. Tosi, B. Besse, S.P. Chawla, L. Bazhenova, J.C. Krauss, Y.K. Chae, M. Barve, I. Garrido-Laguna, S.V. Liu, P. Conkling, T. John, M. Fakih, D. Sigal, H.H. Loong, G.L. Buchschacher, P. Garrido, J. Nieva, C. Steuer, T.R. Overbeck, D.W. Bowles, E. Fox, T. Riehl, E. Chow-Maneval, B. Simmons, N. Cui, A. Johnson, S. Eng, T.R. Wilson, G.D. Demetri. - In: LANCET ONCOLOGY. - ISSN 1470-2045. - 21:2(2020 Feb), pp. 271-282.

Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials / A. Drilon, S. Siena, R. Dziadziuszko, F. Barlesi, M.G. Krebs, A.T. Shaw, F. de Braud, C. Rolfo, M. Ahn, J. Wolf, T. Seto, B.C. Cho, M.R. Patel, C. Chiu, T. John, K. Goto, C.S. Karapetis, H. Arkenau, S. Kim, Y. Ohe, Y. Li, Y.K. Chae, C.H. Chung, G.A. Otterson, H. Murakami, C. Lin, D.S.W. Tan, H. Prenen, T. Riehl, E. Chow-Maneval, B. Simmons, N. Cui, A. Johnson, S. Eng, T.R. Wilson, R.C. Doebele. - In: LANCET ONCOLOGY. - ISSN 1470-2045. - 21:2(2020 Feb), pp. 261-270.

Concurrent small cell transformation and emergence of trans-C797S and T790M mutations under sequential treatment with EGFR inhibitors in lung adenocarcinoma / E.G. Pizzutilo, C. Lauricella, G. Cerea, L. Giannetta, G. Tomasello, S. Stabile, V. Motta, S. Alexiadis, F. Scaglione, A. Vanzulli, M. Torre, E. Bonoldi, S. Veronese, S. Siena, A. Sartore-Bianchi. - In: JCO PRECISION ONCOLOGY. - ISSN 2473-4284. - 2020(2020). [Epub ahead of print]